NO894001L - Optalmiske suspensjoner. - Google Patents

Optalmiske suspensjoner.

Info

Publication number
NO894001L
NO894001L NO89894001A NO894001A NO894001L NO 894001 L NO894001 L NO 894001L NO 89894001 A NO89894001 A NO 89894001A NO 894001 A NO894001 A NO 894001A NO 894001 L NO894001 L NO 894001L
Authority
NO
Norway
Prior art keywords
weight
eye
suspensions
suspension
ophthalmic medicament
Prior art date
Application number
NO89894001A
Other languages
English (en)
Other versions
NO176696C (no
NO176696B (no
NO894001D0 (no
Inventor
Santos Kumar Chandrasekaran
Roy Duane Archibald
Jeffrey Paul Davis
Yangsheng Su
Original Assignee
Insite Vision Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Insite Vision Inc filed Critical Insite Vision Inc
Publication of NO894001D0 publication Critical patent/NO894001D0/no
Publication of NO894001L publication Critical patent/NO894001L/no
Publication of NO176696B publication Critical patent/NO176696B/no
Publication of NO176696C publication Critical patent/NO176696C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Liquid Crystal Substances (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO894001A 1988-02-08 1989-10-06 Fremgangsmåte for fremstilling av henholdsvis et medikamentavleveringssystem og et tåreerstatningssystem NO176696C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15376288A 1988-02-08 1988-02-08
US30111489A 1989-01-25 1989-01-25
PCT/US1989/000451 WO1989006964A1 (en) 1988-02-08 1989-02-08 Ophthalmic suspensions

Publications (4)

Publication Number Publication Date
NO894001D0 NO894001D0 (no) 1989-10-06
NO894001L true NO894001L (no) 1989-12-08
NO176696B NO176696B (no) 1995-02-06
NO176696C NO176696C (no) 1995-05-16

Family

ID=26850837

Family Applications (1)

Application Number Title Priority Date Filing Date
NO894001A NO176696C (no) 1988-02-08 1989-10-06 Fremgangsmåte for fremstilling av henholdsvis et medikamentavleveringssystem og et tåreerstatningssystem

Country Status (10)

Country Link
EP (1) EP0362321B1 (no)
JP (1) JP2814637B2 (no)
AT (1) ATE91408T1 (no)
CA (1) CA1336500C (no)
DE (1) DE68907545T2 (no)
DK (2) DK167344B1 (no)
ES (1) ES2012634A6 (no)
IE (1) IE63392B1 (no)
NO (1) NO176696C (no)
WO (1) WO1989006964A1 (no)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5461081A (en) * 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5521222A (en) * 1989-09-28 1996-05-28 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653018A1 (fr) * 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique non solide a base de microparticules de polymere contenant au moins un principe actif en suspension dans un milieu dispersant et procede de preparation de ladite composition.
US6017521A (en) * 1989-10-31 2000-01-25 Columbia Laboratories, Inc. Use of polycarboxylic acid polymers to treat vaginal infections
DK0431719T3 (da) * 1989-10-31 1995-02-27 Columbia Lab Inc Vaginalt vævsbefugtende præparat
DK0500807T3 (da) * 1989-10-31 2000-02-07 Columbia Lab Inc Præparat og fremgangsmåde til befugtning af væv
DK0429156T3 (da) * 1989-10-31 1995-01-16 Columbia Lab Inc Fremgangsmåde til fugtiggørelse af væv og præparat hertil
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
DE69119217T2 (de) * 1990-08-21 1996-10-31 Theratech Inc Zusammensetzungen zur kontrollierten freigabe
US5686094A (en) * 1991-04-01 1997-11-11 Theratech, Inc. Controlled release formulations for the treatment of xerostomia
CA2055522A1 (en) * 1990-12-12 1992-06-13 Masako Andoh Microspheres for ophthalmic use
JP2873530B2 (ja) * 1991-12-13 1999-03-24 参天製薬株式会社 ニュートン型粘性を示すカルボキシビニルポリマー含有点眼液基剤
US5292517A (en) * 1992-02-25 1994-03-08 Allergan, Inc. pH sensitive, reversible gelling, copolymeric erodible drug delivery system
WO1994010976A1 (en) * 1992-11-16 1994-05-26 Ciba Vision Ag, Hettlingen Polyvinyl alcohol/borate ophthalmic drug delivery system
WO1994012217A1 (en) * 1992-12-02 1994-06-09 Insite Vision Incorporated Cyclodextrin and polymer based drug delivery system
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
WO1995005803A1 (en) * 1993-08-20 1995-03-02 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
US5474985A (en) * 1993-12-22 1995-12-12 The Regents Of The University Of California Preventing and treating elevated intraocular pressure associated with administered or endogenous steroids using non-steroidal cyclooxygenase inhibitors
AU1567795A (en) * 1994-01-14 1995-08-01 Lee Shahinian Jr. A method for sustained and extended corneal analgesia
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
IL114193A (en) * 1994-06-20 2000-02-29 Teva Pharma Ophthalmic pharmaceutical compositions based on sodium alginate
US5849879A (en) * 1994-11-03 1998-12-15 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5789169A (en) * 1994-11-03 1998-08-04 Regents Of The University Of California Methods for the diagnosis of glaucoma
US5606043A (en) 1994-11-03 1997-02-25 The Regents Of The University Of California Methods for the diagnosis of glaucoma
US5603929A (en) * 1994-11-16 1997-02-18 Alcon Laboratories, Inc. Preserved ophthalmic drug compositions containing polymeric quaternary ammonium compounds
AUPN327695A0 (en) * 1995-05-30 1995-06-22 Chemeq Pty. Limited Chemotherapeutic compositions
US5674888A (en) * 1995-06-07 1997-10-07 University Of California Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
US5599535A (en) * 1995-06-07 1997-02-04 Regents Of The University Of California Methods for the cyto-protection of the trabecular meshwork
ZA966579B (en) * 1995-08-04 1998-02-02 Wakamoto Pharma Co Ltd O/W emulsion composition for eye drops.
US6596777B1 (en) 1997-05-29 2003-07-22 Mcneil-Ppc, Inc. Moisture containing compositions that are spreadable onto and adherable to biomembranes
US6171788B1 (en) 1997-01-28 2001-01-09 The Regents Of The University Of California Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US6475724B1 (en) 1997-01-28 2002-11-05 The Regents Of The University Of California Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
US7138511B1 (en) 1997-01-28 2006-11-21 The Regents Of The University Of California Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
DE19729879C2 (de) 1997-07-11 1999-07-08 Mann Gerhard Chem Pharm Fab Lagerstabile ophthalmische Zusammensetzungen, umfassend Diclofenac und Ofloxacin
US6258350B1 (en) 1999-01-20 2001-07-10 Alcon Manufacturing, Ltd. Sustained release ophthalmic formulation
US6699492B2 (en) * 1999-03-31 2004-03-02 Insite Vision Incorporated Quinolone carboxylic acid compositions and related methods of treatment
CN100467066C (zh) 2001-08-10 2009-03-11 东丽株式会社 一种通过包含琼脂增强了眼用药物渗透性的滴眼液
US7001615B1 (en) 2001-12-07 2006-02-21 Alcon, Inc. Sustained release ophthalmic, otic and nasal suspension
JP4777477B2 (ja) 2009-09-30 2011-09-21 ロート製薬株式会社 点眼剤
TW201309343A (zh) * 2011-02-10 2013-03-01 參天製藥股份有限公司 經改善親水性藥物之藥物移行性之水性組成物
WO2014035451A1 (en) 2012-08-31 2014-03-06 Bausch & Lomb Incorporated Ophthalmic compositions with wax esters
AU2012312816A1 (en) 2011-09-22 2014-04-24 Bausch & Lomb Incorporated Ophthalmic gel compositions
HUE059639T2 (hu) 2015-01-26 2022-12-28 Bausch & Lomb Szemészeti szuszpenzió kompozíció
WO2020159690A1 (en) 2019-01-30 2020-08-06 Bausch & Lomb Incorporated Crosslinked polymeric network and use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947573A (en) * 1969-12-01 1976-03-30 Burton, Parsons And Company, Inc. Opthalmic solution
JPS6056684B2 (ja) * 1977-11-07 1985-12-11 東興薬品工業株式会社 点眼剤
US4271143A (en) * 1978-01-25 1981-06-02 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage
US4478818A (en) * 1982-12-27 1984-10-23 Alza Corporation Ocular preparation housing steroid in two different therapeutic forms
US4474751A (en) * 1983-05-16 1984-10-02 Merck & Co., Inc. Ophthalmic drug delivery system utilizing thermosetting gels
US4615697A (en) * 1983-11-14 1986-10-07 Bio-Mimetics, Inc. Bioadhesive compositions and methods of treatment therewith

Also Published As

Publication number Publication date
DK493689D0 (da) 1989-10-06
WO1989006964A1 (en) 1989-08-10
DK47793D0 (da) 1993-04-27
EP0362321B1 (en) 1993-07-14
DK493689A (da) 1989-12-01
NO176696C (no) 1995-05-16
DE68907545D1 (de) 1993-08-19
DK168727B1 (da) 1994-05-30
CA1336500C (en) 1995-08-01
EP0362321A4 (en) 1991-05-08
ATE91408T1 (de) 1993-07-15
IE63392B1 (en) 1995-04-19
EP0362321A1 (en) 1990-04-11
DE68907545T2 (de) 1993-10-28
DK167344B1 (da) 1993-10-18
NO176696B (no) 1995-02-06
JPH02503201A (ja) 1990-10-04
ES2012634A6 (es) 1990-04-01
DK47793A (da) 1993-04-27
NO894001D0 (no) 1989-10-06
IE890323L (en) 1989-08-08
JP2814637B2 (ja) 1998-10-27

Similar Documents

Publication Publication Date Title
NO894001D0 (no) Optalmiske suspensjoner.
ES2103815T3 (es) Suspensiones oftalmicas.
DE69424275T2 (de) Alkalische ophthalmische suspensionen
CA2086120A1 (en) Topical ophthalmic suspensions
ATE205079T1 (de) Flüssiges ophthalmologisches abgabesystem mit verzögerter freisetzung
KR850003327A (ko) 물 분리제
ATE60997T1 (de) Vernetzte poroese polymere fuer eine kontrollierte wirkstoffabgabe.
US4592752A (en) Non-optical corneal drug delivery
KR920011478A (ko) 안과용 미소구
Durrani et al. A novel ocular delivery system for phenylephrine hydrochloride
MX9207548A (es) Suspensiones oftalmicas topicas.

Legal Events

Date Code Title Description
MK1K Patent expired